ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Identification of Interleukin-1-Beta Inhibitors in Gouty Arthritis Using an Integrated Approach Based on Network Pharmacology, Molecular Docking, and Cell Experiments

Zeng, Liying; Lin, Zekun; Kang, Pan; Zhang, Meng; Tang, Hongyu; Li, Miao; Xu, Kun; Liu, Yamei; Jiang, Ziyun*; Huo, Shaochuan*广州中医药大学; 郑州大学; 1
Evidence-based Complementary and Alternative Medicine2022-9-19DOI: 10.1155/2022/2322417
1被引6阅读
引用收藏
分享

摘要

Background. This study aimed to investigate the molecular mechanism of Tongfengding capsule (TFDC) in treating immunein"ammatory diseases of gouty arthritis (GA) and interleukin-1-beta (IL-1") inhibitors by using network pharmacology, molecular docking, and cell experiments. Methods. In this study, the compounds of TFDC and the potential in"ammatory targets of GA were obtained from Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP), Online Mendelian Inheritance in Man (OMIM), and GeneCards databases. The TFDC-GA-potential targets interaction network was accomplished by the STRING database. The TFDC-active compound-potential target-GA network was constructed using Cytoscape software. Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were used to further explore the GA mechanism and therapeutic eoects of TFDC. Quantitative real-time PCR (qPCR) was used to verify whether the TFDC inhibited IL-1" in GA. Molecular docking technology was used to analyze the optimal eoective compounds from the TFDC for docking with IL-1". Result. 133 active compounds and 242 targets were screened from the TFDC, and 25 of the targets intersected with GA in"ammatory targets, which were considered as potential therapeutic targets. Network pharmacological analysis showed that the TFDC active compounds such as quercetin, stigmasterol, betavulgarin, rutaecarpine, naringenin, dihydrochelerythrine, and dihydrosanguinarine had better correlation with GA in"ammatory targets such as PTGS2, PTGS1, NOS2, SLC6A3, HTR3A, PPARG, MAPK14, RELA, MMP9, and MMP2. The immune-in"ammatory signaling pathways of the active compounds for treating GA are IL-17 signaling pathway, TNF signaling pathway, NOD-like receptor signaling pathway, NF-kappa B signaling pathway, Toll-like receptor signaling pathway, HIF-1 signaling pathway, etc. The TFDC reduced IL-1" mRNA expression in GA by qPCR. Molecular docking results suggested that rutaecarpine was the most appropriate natural IL-1" inhibitor. Conclusion. Our findings provide an essential role and bases for further immune-in"ammatory studies on the molecular mechanisms of TFDC and IL-1" inhibitors development in GA.

学科与关键词

关键词
RATSINFLAMMATIONMANAGEMENTDISEASE
相关
加载中…
  • Treatment of gouty arthritis with traditional Chinese medicine decoction: Meta-analysis, network pharmacology analysis, and molecular docking
    Qu, Pengda; Du, Shiyu; Wang, Wei; Peng, Zhaorong; Hu, Qian; Wang, Haiyang; Tang, Xiaohu*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2024, 103(1): e36722.
  • Kaempferol Attenuates Gouty Arthritis by Regulating the Balance of Th17/Treg Cells and Secretion of IL-17
    Li, Nan; Chen, Shulin; Deng, Weiqing; Gong, Zhaohui; Guo, Yu*; Zeng, Shan*; Xu, Qiang*Inflammation, 2023, 46(5): 1901-1916.
  • Clinical efficacy evaluation and potential mechanism prediction on Guizhi-Shaoyao-Zhimu decoction in the treatment of gouty arthritis based on meta-analysis, network pharmacology analysis, and molecular docking
    Qu, Pengda; Wang, Haiyang; Wang, Wei; Hu, Qian; Du, Shiyu; Peng, Zhaorong; Tang, Xiaohu*Medicine; analytical reviews of general medicine, neurology, psychiatry, dermatology, and pediatries, 2023, 102(47): e35973.
查看全部 →

发表信息

论文状态
公开发表
期刊
Evidence-based Complementary and Alternative Medicine
发表日期
2022-09-19
卷期
第 2022 卷
页码
2322417
DOI
10.1155/2022/2322417
语言
ENGLISH
期刊等级
4区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [82004395]; China Postdoctoral Science Foundation [2018M633088]; Shenzhen Futian District Health and Public Welfare Scientific Research Project [FTWS2020058, FTWS2020059]

作者

  • Z

    Zeng, Liying (第一作者)

    guangzhou univ chinese med

  • L

    Lin, Zekun

    guangzhou univ chinese med

查看全部 10 位作者收起作者
  • K

    Kang, Pan

    guangzhou univ chinese med · 1

  • Z

    Zhang, Meng

    henan prov peoples hosp · henan univ · zhengzhou univ

  • T

    Tang, Hongyu

    guangzhou univ chinese med · 1

  • L

    Li, Miao

    guangzhou univ chinese med · 1

  • X

    Xu, Kun

    shanghai acad tradit chinese med · shanghai univ tradit chinese med

  • L

    Liu, Yamei

    guangzhou univ chinese med

  • J

    Jiang, Ziyun (通讯)

    guangzhou univ chinese med

  • H

    Huo, Shaochuan (通讯)

    guangzhou univ chinese med

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417